BioSpace News Archive

Business

Children’s Hospital of Philadelphia and MOREHealth Announce Agreement to Offer Remote Second Opinions

Children’s Hospital of Philadelphia and MOREHealth, a global healthcare company, announced their new agreement that enables patients access to CHOP’s exceptional physicians through MOREHealth’s Physician Collaboration Platform™.

August 5, 2020
·
2 min read
Biotech Beach

Therapeutic Solutions International Reports Reduction of Inflammation Associated Memory Impairment by QuadraMune™ Administration

Animal Data has Potential Implications for Ongoing COVID-19 Prevention Study Company Continues Quest to Dominate Intellectual Property Regarding COVID-19 Associated Pathologies

August 5, 2020
·
2 min read
BioCapital

COVID-19 rates higher among minority, socioeconomically disadvantaged children

Children’s National Hospital’s Pediatric study results mirror disparities found in adult populations across the U.S

August 5, 2020
·
5 min read
Business

Kamada to Announce Second Quarter Ended June 30, 2020 Financial Results and Host Conference Call on August 12, 2020

Kamada Ltd., plasma-derived biopharmaceutical company, announced that it will release financial results for the second quarter ended June 30, 2020, prior to the open of the U.S. financial markets on Wednesday, August 12, 2020.

August 5, 2020
·
2 min read
Business

InspireMD Announces Second Quarter 2020 Financial Results

In the second quarter the Company was granted approval to market itsCGuard™ MicroNet stent in Brazil and completed an $11.5 million capital raise; reported outstanding results in studies treating patients with the CGuard™ MicroNET stent

August 5, 2020
·
16 min read
BioCapital

Cerecor to Present at the 2020 Wedbush PacGrow Healthcare Virtual Conference

Cerecor Inc. announced that Michael F. Cola, President and Chief Executive Officer, will present at the 2020 Wedbush PacGrow Healthcare Virtual Conference on Tuesday, August 11, 2020 at 8:00 a.m. EDT.

August 5, 2020
·
3 min read
Business

Harvard Bioscience Announces Second Quarter 2020 Financial Results

Accelerated cost reduction, cash conservation actions drive increased operating income, reduced net debt

August 5, 2020
·
6 min read
Business

Fulcrum Therapeutics to Host Second Quarter 2020 Financial Results Conference Call and Webcast on Tuesday, August 11, 2020 at 8:00 a.m. ET

Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, announced that its second quarter 2020 financial results will be released on Tuesday, August 11, 2020 before the U.S. financial markets open.

August 5, 2020
·
1 min read
Business

Constellation Pharmaceuticals Announces Second-Quarter 2020 Financial Results, Provides Regulatory Update

Constellation has aligned with the FDA on the design of MANIFEST-2, the pivotal Phase 3 clinical trial for CPI-0610 expected to begin in 2H20

August 5, 2020
·
11 min read
Business

Cyclacel Pharmaceuticals to Release Second Quarter 2020 Financial Results

Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing innovative medicines based on cancer cell biology, will announce second quarter 2020 financial results on Wednesday, August 12, 2020.

August 5, 2020
·
3 min read